Increased orosomucoid in urine is an independent predictor of cardiovascular and all-cause mortality in patients with type 2 diabetes at 10 years of follow-up

Journal of Diabetes and its Complications

Volumn 27, Issue 6, 2013, Pages 570-575

  Svendstrup, Mathilde ^a   Christiansen, Merete Skovdal ^a   Magid, Erik ^a   Hommel, Eva ^b   Feldt Rasmussen, Bo ^c  

^a AMAGER HOSPITAL   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

^c University of Copenhagen   (Denmark)

Author keywords

Cardiovascular mortality; Diabetes; Mortality; Orosomucoid; Urinary orosomucoid excretion rate

Indexed keywords

CHOLESTEROL; CREATININE; INSULIN; OROSOMUCOID;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RETINOPATHY; SMOKING; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

CARDIOVASCULAR MORTALITY; DIABETES; MORTALITY; OROSOMUCOID; URINARY OROSOMUCOID EXCRETION RATE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OROSOMUCOID; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84887123438     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2013.05.008     Document Type: Article

References (37)

1. K.M. Choi, K.W. Lee, N.H. Kim, C.G. Park, and H.S. Seo Inflammation, insulin resistance, and glucose intolerance in acute myocardia infarction patients without a previous diagnosis of diabetes mellitus The Journal of Clinical Endocrinology and Metabolism 90 1 2005 175 180
2. M.S. Christiansen, E. Hommel, E. Magid, and B. Feldt-Rasmussen Orosomucoid in urine predicts cardiovascular and over-all mortality in patients with type II diabetes Diabetologia 45 2002 115 120
3. M.S. Christiansen, S. Blirup-Jensen, L. Foged, M. Larsen, and E. Magid A particle-enhanced turbidimetric immunoassay for quantitative determination of orosomucoid in urine: Development, validation and reference values Clinical Chemistry and Laboratory Medicine 42 10 2004 1168 1177
4. M.S. Christiansen, E. Hommel, E. Magid, and B. Feldt-Rasmussen Orosomucoid in urine is a powerful predictor of cardiovascular mortality in normoalbuminuric patients with type II diabetes at five years of follow-up Diabetologia 48 2005 386 393
5. M.S. Christiansen, K. Iversen, C.T. Larsen, J.P. Goetze, E. Hommel, and J. Mølvig Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetes Scandinavian Journal of Clinical and Laboratory Investigation 69 2 2009 272 281
6. M.S. Christiansen, E. Hommel, L. Friberg, J. Mølvig, E. Magid, and B. Feldt-Rasmussen Increased urinary orosomucoid excretion is not related to impaired renal function in patients with type 2 diabetes Journal of Diabetes and its Complications 24 2010 28 36
7. B.B. Duncan, M.I. Schmidt, J.S. Pankow, C.M. Ballantyne, D. Couper, and A. Vigo Low-grade systemic inflammation and the development of type 2 diabetes Diabetes 52 2003 1799 1805
8. G. Engström, L. Stavenow, B. Hedblad, P. Lind, K.-F. Eriksson, and L. Janzon Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke Diabetes 52 2003 442 447
9. M.A. Gall, K. Borch-Johnson, P. Hougaard, F.S. Nielsen, and H. Parving Albuminuria and poor glycemic control predict mortality in NIDDM Diabetes 44 1995 1303 1309
10. K. Gu, C.C. Cowie, and M.I. Harris Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993 Diabetes Care 21 1998 1138 1145
11. M.B. Hansen, M.L. Jensen, and B. Carstensen Causes of death among diabetic patients in Denmark Diabetologia 55 2 2012 294 302
12. M.K. Heliövaara, M. Herz, A.-M. Teppo, E. Leinonen, and P. Ebeling Pioglitazone has anti-inflammatory effects in patients with type 2 diabetes Journal of Endocrinological Investigation 30 2007 292 297
13. S. Ito, A. Tsuda, T. Momotsu, K. Igarashi, S. Kasahara, and K. Satoh Urinary orosomucoid excretion rate in patients with non-insulin-dependent diabetes mellitus Acta Endocrinologica (Copenhagen) 120 5 1989 584 590
14. S. Jain, A. Rajput, Y. Kumar, N. Uppuluri, A.S. Arvind, and U. Tatu Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder The Journal of the Association of Physicians of India 53 2005 513 520
15. R.J. Jarrett, G.C. Viberti, A. Argyropoulos, R.D. Hill, U. Mahmud, and T.J. Murrells Microalbuminuria predicts mortality in non-insulin-dependent diabetes Diabetic Medicine 1 1 1984 17 19
16. H. Jiang, G. Guan, R. Zhang, G. Liu, H. Liu, and X. Hou Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy Nephrology 14 2009 332 337
17. sICAM-a) and inflammatory markers in non-insulin dependent diabetes mellitus (NIDDM) Sborník Lékar̆ský 99 2 1998 97 101
18. Y.S. Lee, J.W. Choi, I. Hwang, J.W. Lee, J.H. Lee, and A.Y. Kim Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation The Journal of Biological Chemistry 285 29 2010 22174 22185
19. Y. Lin, M.W. Rajala, J.P. Berger, D.E. Moller, N. Barzilai, and P.E. Scherer Hyperglycemia-induced production of acute phase reactants in adipose tissue The Journal of Biological Chemistry 276 45 2001 42077 42083
20. 1-microglobulin, and IgG Clinical Chemistry 51 11 2005 2052 2058
21. C.E. Mogensen Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes The New England Journal of Medicine 310 1984 356 360
22. C.E. Mogensen, W.F. Keane, P.H. Bennett, G. Jerums, H.H. Parving, and P. Passa Prevention of diabetic renal disease with special reference to microalbuminuria The Lancet 346 1995 1080 1084
23. L. Monesi, M. Baviera, I. Marzona, F. Avanzini, G. Monesi, and A. Nobili Prevalence, incidence and mortality of diagnosed diabetes: Evidence from an Italian population-based study Diabetic Medicine 29 3 2012 385 392
24. N.J. Morrish, L.K. Stevens, J. Head, J.H. Fuller, R.J. Jarret, and H. Keen A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the Multinational Study of Vascular Disease in Diabetics) I: Causes and death rates Diabetologia 33 1990 538 541
25. T. Narita, H. Sasaki, M. Hosoba, T. Miura, N. Yoshioka, and T. Morii Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients Diabetes Care 27 5 2004 1176 1181
26. A. Neil, M. Hawkins, M. Potok, M. Thorogood, D. Cohen, and J. Mann A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM Diabetes Care 16 1993 996 1003
27. J.C. Pickup, M.B. Mattock, G.D. Chusney, and D. Burt NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrom X Diabetologia 40 1997 1286 1292
28. 1-acid flycoprotein in type 1 diabetic patients is related to vascular function Glycoconjugate Journal 18 2001 261 268
29. R. Ross The pathogenesis of arteriosclerosis: A perspective for the 1990s Nature 362 6423 1993 801 809
30. A. Schmitz, and M. Vaeth Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients Diabetic Medicine 5 1988 126 134
31. R.W. Schrier, R.O. Estacio, A. Esler, and P. Mehler Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes Kidney International 61 3 2002 1086 1097
32. S.R. Seshasai, S. Kaptoge, A. Thompson, E. Di Angelantonio, P. Gao, and N. Sarwar Diabetes mellitus, fasting glucose, and risk of cause-specific death The New England Journal of Medicine 364 9 2011 829 841
33. Snorgaard, O.; Drivsholm, T.B.; Breum, L.; Christiansen, J.S.; Hansen, C.; Henderson, D.; et al. (2011). Guidelines for type 2-diabetes. En fælles behandlingsvejledning med enslydende kliniske behandlingsmål. Dansk Endokrinologisk Selskab, Dansk Selskab for Almen Medicin og Institut for Rationel Farmakoterapi, Danmark.
34. J.M. Stephenson, S. Kenny, L.K. Stevens, J.H. Fuller, and E. Lee Proteinuria and mortality in diabetes: The WHO Multinational Study of Vascular Disease in Diabetes Diabetic Medicine 12 2 1995 149 155
35. G. Viberti, and N.M. Wheeldon Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: A blood pressure-independent effect Circulation 106 6 2002 672 678
36. J. Wu, Y.-D. Chen, J.-K. Yu, X.-L. Shi, and W. Gu Analysis of urinary proteomic patterns for type 2 diabetic nephropathy by ProteinChip Diabetes Research and Clinical Practice 91 2 2011 213 219
37. P. Zürbig, G. Jerums, P. Hovind, R.J. Macisaac, H. Mischak, and S.E. Nielsen Urinary proteomics for early diagnosis in diabetic nephropathy Diabetes 61 12 2012 3304 3313